1. Micro-RNAs in cognition and cognitive disorders: Potential for novel biomarkers and therapeutics.
- Author
-
Woldemichael BT and Mansuy IM
- Subjects
- Animals, Biomarkers blood, Biomarkers cerebrospinal fluid, Cognition Disorders drug therapy, Humans, Learning drug effects, MicroRNAs blood, MicroRNAs cerebrospinal fluid, Neuronal Plasticity drug effects, Neuronal Plasticity genetics, Oligonucleotides administration & dosage, Cognition drug effects, Cognition Disorders genetics, MicroRNAs genetics, Oligonucleotides therapeutic use
- Abstract
Micro-RNAs (miRNAs) are small regulatory non-coding RNAs involved in the regulation of many biological functions. In the brain, they have distinct expression patterns depending on region, cell-type and developmental stage. Their expression profile is altered by neuronal activation in response to behavioral training or chemical/electrical stimulation. The dynamic changes in miRNA level regulate the expression of genes required for cognitive processes such as learning and memory. In addition, in cognitive dysfunctions such as dementias, expression levels of many miRNAs are perturbed, not only in brain areas affected by the pathology, but also in peripheral body fluids such as serum and cerebrospinal fluid. This presents an opportunity to utilize miRNAs as biomarkers for early detection and assessment of cognitive dysfunctions. Further, since miRNAs target many genes and pathways, they may represent key molecular signatures that can help understand the mechanisms of cognitive disorders and the development of potential therapeutic agents., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF